Literature DB >> 77192

Use of prostaglandin E1 for emergency palliation of symptomatic coarctation of the Aorta.

T P Graham, G F Atwood, R J Boucek.   

Abstract

Prostaglandin E1 (PGE1) was infused into the pulmonary artery in a 1-day-old infant with symptomatic coarctation. Umbilical artery pressure rose from 50/40 mm Hg before infusion to 83/48 mm Hg after infusion, indicating significant improvement in lower-body perfusion. Successful coarctation repair was performed during continued PGE1 infusion. To our knowledge, this is the first reported patient in whom PGE1 has been used for successful emergency palliation of symptomatic coarctation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 77192     DOI: 10.1002/ccd.1810040114

Source DB:  PubMed          Journal:  Cathet Cardiovasc Diagn        ISSN: 0098-6569


  3 in total

1.  A clinical prediction model to estimate the risk for coarctation of the aorta in the presence of a patent ductus arteriosus.

Authors:  Jonathan H Soslow; Ann Kavanaugh-McHugh; Li Wang; Daniel L Saurers; Neeru Kaushik; Stacy A S Killen; David A Parra
Journal:  J Am Soc Echocardiogr       Date:  2013-09-23       Impact factor: 5.251

2.  Effect of prostaglandin on early surgical mortality in obstructive lesions of the systemic circulation.

Authors:  F Leoni; J C Huhta; J Douglas; R MacKay; M R de Leval; F J Macartney; J Stark
Journal:  Br Heart J       Date:  1984-12

Review 3.  Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions.

Authors:  Smita Akkinapally; Shilpa G Hundalani; Madhulika Kulkarni; Caraciolo J Fernandes; Antonio G Cabrera; Binoy Shivanna; Mohan Pammi
Journal:  Cochrane Database Syst Rev       Date:  2018-02-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.